AVEO Pharmaceuticals, Inc. Sets IPO Terms

Published: Feb 24, 2010

Bookmark and Share

Private Equity Hub -- AVEO Pharmaceuticals Inc., a Cambridge, Mass.-based oncology drug company, has set its IPO terms to seven million common shares being offered at between $13 and $15 per share. It would have an initial market cap of approximately $415 million, were it to price at the high end of its range.

Back to news